Clinical Trial Update: Efficacy and Safety Study to Treat Subjects With Symptomatic Internal Hemorrhoids [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating efficacy and safety for symptomatic internal hemorrhoids sponsored by Ventrus Biosciences has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Internal Hemorrhoids

Drugs mentioned

• Investigational product

Snippet

Sponsor: Ventrus Biosciences, Inc | Conditions: Internal Hemorrhoids | Phase 3 | Status: TERMINATED